OMS treatment amplified Mabc-induced expression of M1-related proinflammatory cytokines and inducible nitric oxide synthase, and significantly downregulated arginase-1 expression in murine macrophages. The gene discussed is ARG1; the disease is opsoclonus-myoclonus syndrome.